Clin2
NCT04945213Possibly a fitRecruiting

Biperiden to prevent seizures after traumatic brain injury

Brain Injury Traumatic ModerateBrain Injury Traumatic SeverePost Traumatic Epilepsy

Part of Brain & nervous system, Injuries & trauma clinical trials.

This trial tests whether biperiden can lower the chance of developing epilepsy after an acute traumatic brain injury (with bleeding or bruising seen on CT). If you qualify, you would get the medicine or a placebo soon after the injury, and researchers will compare outcomes.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
312 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You must be able to give informed consent (or have a legal representative).
  • Age 18 to 75 years.
  • You were admitted with a moderate to severe traumatic brain injury and your brain CT shows bleeding in the brain and/or bruising (contusion).
  • Your first study dose/placebo must be given within 18 hours after the brain injury.
  • You should not have a history of epilepsy, prior seizures, or taking seizure medicines.
  • You cannot be pregnant and you cannot be taking biperiden already; you also must not be in another clinical trial at the time of randomization.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07072624Recruiting· Phase 4
Preventing seizures after severe head injury

This trial tests whether giving medication right after a serious head injury can prevent early seizures. It may help people with certain types of brain injuries seen on CT scans.

Chandigarh, Punjab
NCT06866691Recruiting· Phase 4
Seizure prevention after traumatic brain injury

This trial tests two medicines, levetiracetam and lacosamide, to see which works better at preventing seizures in people who have had a traumatic brain injury. The goal is to find the safest and most effective way to protect your brain after injury.

Winston-Salem, North Carolina
NCT07535736Not yet recruiting
Seizure prevention after traumatic brain injury

This study tests whether giving an anti-seizure medicine soon after a traumatic brain injury can prevent seizures. It may help people who arrive at the hospital within 24 hours of their injury.

NCT07336992Not yet recruiting· Phase 3
Seizure prevention medicine for brain bleed recovery

This study tests whether a medicine called levetiracetam can help people recover better after a brain bleed. Half of the participants will receive the medicine, and half will receive a placebo. The goal is to see if this medicine can help improve recovery.

Bron
NCT07166393Not yet recruiting· Phase 2/Phase 3
Valproic acid for traumatic brain injury

This trial tests whether giving an FDA-approved seizure medication (valproic acid) soon after a moderate to severe brain injury can help reduce damage and improve recovery. If you arrive at the emergency room quickly after your head injury, you might be able to join.

Birmingham, Alabama
NCT04573803Not yet recruiting· Phase 3
Comparing two medicines to prevent or treat seizures after head injury

This study looks at two medicines (phenytoin and levetiracetam) to see which works better for treating or preventing seizures that can happen after a traumatic brain injury. It aims to find the safest and most effective option for patients.

Hear when a new Brain Injury Traumatic Moderate trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.